Matthieu Boucher, Ph.D.
Psychiatry, Central Nervous System, Women’s Health & Allergy
National Field Manager, Medical Affairs, Neurosciences
Otsuka Canada Pharmaceutical Inc.
2250, boul. Alfred-Nobel, bureau 301
Ville Saint-Laurent, Québec H4S 2C9
Email: matthieu.boucher [at] otsuka-ca.com
Tel: 514-814-1540
Fax: 514-332-3107
Web: www.otsukacanada.com
Lionel Breton, Ph.D.
Scientific Director, Advanced Research at L’Oreal
L'Oréal
20, Avenue de Paris, 78000 Versailles, France
Email: lbreton [at] rd.loreal.com
Tel: +33 6 63 18 99 38
Fax: +33 6 17 05 15 38
Lorella Garofalo, Ph.D.
Drug Development
Head of Regulatory Affairs, Canada
Global Regulatory Affairs, International
Pfizer Canada ULC
17300 Autoroute Trans Canada
Kirkland, Quebec H9J 2M5
Email: lorella.garofalo [at] pfizer.com
Tel: 514-426-7432
Fax: 514-426-6824
Web: www.pfizer.ca | www.facebook.com/Pfizer.Canada | @PfizerCA
John W. Gillard, Ph.D.
SVP Research and Product Development
Kalgene Pharmaceuticals Inc.
Email: John.gillard [at] kalgene.com
Tel: 514 887-8632
Joseph Mancini, Ph.D.
Diabetes/Inflammation
Head of Biology; Sr Director at adMare BioInnovations
adMare's Innovation Centre
7171 Frederick-Banting
Montreal, Quebec H4S 1Z9
Email: joseph.mancini [at] mcgill.ca
Tel: 617-691-7534
Karen Meerovitch, Ph.D.
Drug/clinical development Ophthalmology
Vice-President, Clinical Development
Mimetogen Pharmaceuticals, Inc.
1000 de La Gauchetière St. West
Suite 900
Montréal, Québec H3B 5H4
Email: karen.meerovitch [at] mimetogen.com
Tel: 514-924-7484
Christopher Wright, Ph.D.
Neurology
Senior Vice President, Chief Development Officer
Ironwood Pharmaceuticals Inc
100 Summer Street
Suite 2300
Boston MA 02110
Email: ciwright1983 [at] comcast.net
Tel: 1 857 383 1664
Web: www.ironwoodpharma.com